Disaster Relief-Pharmacy Medicaid State Plan Amendment 21-0033 Public Notice

Notice: Disaster Relief-Pharmacy Medicaid State Plan Amendment 21-0033 Public Notice is now available online.

Description: The Health Care Authority intends to submit Medicaid State Plan Amendment 21-0033 to cover and reimburse for the administration of monoclonal antibody treatment and drugs to treat COVID-19 that are authorized under the FDA Emergency Use Authorization, regardless of rebate or language in Attachment 3 of the Washington Medicaid State Plan that precludes coverage of investigational or experimental treatments.